Dynamic Wealth Strategies’s Acadia Pharmaceuticals ACAD Stock Holding History

Dynamic Wealth Strategies’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.31K	Hold	131	–	–	﹤0.01%	275
2026 Q1	$2.92K	Hold	131	–	–	﹤0.01%	262
2025 Q4	$3.5K	Hold	131	–	–	﹤0.01%	235
2025 Q3	$2.8K	Hold	131	–	–	﹤0.01%	228
2025 Q2	$2.83K	Hold	131	–	–	﹤0.01%	221
2025 Q1	$2.18K	Buy	+131	New	+$2.38K	﹤0.01%	223
2024 Q4	–	Sell	-131	Closed	-$2K	–	68
2024 Q3	$2K	Hold	131	–	–	﹤0.01%	222
2024 Q2	$2K	Hold	131	–	–	﹤0.01%	229
2024 Q1	$2K	Hold	131	–	–	﹤0.01%	235
2023 Q4	$4.1K	Buy	+131	New	+$3.13K	﹤0.01%	228

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dynamic Wealth Strategies's ACAD Position: Q2 2026 in Review

Dynamic Wealth Strategies held its Acadia Pharmaceuticals (ACAD) position steady in Q2 2026 at 131 shares worth $3.31K. The position accounts for ﹤0.01% of the portfolio, ranked #275.

Dynamic Wealth Strategies first reported a position in ACAD in Q4 2023 and has held it in 10 quarters since. The position peaked at $4.1K in Q4 2023. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

Dynamic Wealth Strategies held 131 shares of Acadia Pharmaceuticals worth $3.31K as of Q2 2026.
Dynamic Wealth Strategies left its Acadia Pharmaceuticals share count unchanged in Q2 2026.
Acadia Pharmaceuticals made up ﹤0.01% of Dynamic Wealth Strategies's portfolio in Q2 2026, its #275 holding.
Dynamic Wealth Strategies first reported a position in Acadia Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
Dynamic Wealth Strategies's Acadia Pharmaceuticals position peaked at $4.1K in Q4 2023.
354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Dynamic Wealth Strategies's 13F filing for Q2 2026, filed 23 Jul 2026.